Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

The scaffold effectively prevents melanoma relapse and aids wound healing.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

New cytokine-targeted therapies show promise for treating alopecia areata.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

Symptom experience doesn't affect medication compliance in liver transplant patients.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Stopping azathioprine improved hair loss and bone marrow issues.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Minoxidil can help regrow hair in people with alopecia areata.